Arthur Zelent

13.1k total citations · 4 hit papers
124 papers, 10.4k citations indexed

About

Arthur Zelent is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Arthur Zelent has authored 124 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Molecular Biology, 59 papers in Hematology and 28 papers in Genetics. Recurrent topics in Arthur Zelent's work include Retinoids in leukemia and cellular processes (81 papers), Acute Myeloid Leukemia Research (58 papers) and Histone Deacetylase Inhibitors Research (29 papers). Arthur Zelent is often cited by papers focused on Retinoids in leukemia and cellular processes (81 papers), Acute Myeloid Leukemia Research (58 papers) and Histone Deacetylase Inhibitors Research (29 papers). Arthur Zelent collaborates with scholars based in United States, United Kingdom and France. Arthur Zelent's co-authors include Pierre Chambon, Martin Petkovich, A. Krust, Philippe Kastner, Samuel Waxman, Fabien Guidez, Andrée Krust, Jonathan D. Licht, Pier Paolo Pandolfi and Susannah Waxman and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Arthur Zelent

124 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cloning of murine α and β retinoic acid receptors and a novel receptor γ predominantly expressed in skin

1989 732 citations Arthur Zelent, Andrée Krust et al. profile →
A third human retinoic acid receptor, hRAR-gamma.

1989 613 citations Arthur Zelent, Pierre Chambon et al. profile →
Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia.

1993 543 citations Susannah Waxman, Arthur Zelent et al. profile →
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia

2012 502 citations Tino Schenk, Louise Howell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arthur Zelent United States	52	8.8k	2.9k	2.8k	1.3k	939	124	10.4k
Clara Nervi Italy	46	8.1k 0.9×	3.1k 1.1×	1.2k 0.4×	775 0.6×	669 0.7×	121	9.2k
SJ Collins United States	27	3.8k 0.4×	2.1k 0.7×	788 0.3×	1.1k 0.8×	421 0.4×	47	5.5k
Nigel J. Brand United Kingdom	31	4.4k 0.5×	648 0.2×	1.9k 0.7×	595 0.5×	604 0.6×	58	5.9k
Denise Sheer United Kingdom	51	6.0k 0.7×	848 0.3×	1.9k 0.7×	1.4k 1.1×	114 0.1×	178	10.9k
Marie‐Pierre Gaub France	36	3.7k 0.4×	455 0.2×	2.3k 0.8×	726 0.6×	380 0.4×	70	5.2k
Norman N. Iscove Canada	43	4.5k 0.5×	2.4k 0.8×	657 0.2×	3.1k 2.4×	77 0.1×	76	9.1k
Jacques Ghysdael France	60	5.9k 0.7×	1.4k 0.5×	2.0k 0.7×	2.9k 2.2×	39 0.0×	181	10.7k
C M Croce United States	46	5.2k 0.6×	1.3k 0.4×	1.4k 0.5×	1.2k 1.0×	44 0.0×	102	8.8k
W. Scott Argraves United States	52	4.5k 0.5×	1.1k 0.4×	928 0.3×	994 0.8×	71 0.1×	99	9.0k
Domenico Delia Italy	43	4.2k 0.5×	438 0.1×	565 0.2×	950 0.7×	164 0.2×	125	6.9k

Countries citing papers authored by Arthur Zelent

Since Specialization

Citations

This map shows the geographic impact of Arthur Zelent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Zelent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Zelent more than expected).

Fields of papers citing papers by Arthur Zelent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur Zelent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Zelent. The network helps show where Arthur Zelent may publish in the future.

Co-authorship network of co-authors of Arthur Zelent

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur Zelent. A scholar is included among the top collaborators of Arthur Zelent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur Zelent. Arthur Zelent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Palusińska, Małgorzata, Yordan Sbirkov, Sven Stengel, et al.. (2025). Synergistic potential of CDK4/6 inhibitors and ATRA in non‐APL AML. British Journal of Haematology. 207(4). 1279–1288. 1 indexed citations

Sbirkov, Yordan, Tino Schenk, Colin Kwok, et al.. (2023). Dual inhibition of EZH2 and G9A/GLP histone methyltransferases by HKMTI-1-005 promotes differentiation of acute myeloid leukemia cells. Frontiers in Cell and Developmental Biology. 11. 1076458–1076458. 9 indexed citations

Stengel, Sven, Kevin Petrie, Yordan Sbirkov, et al.. (2022). Suppression of MYC by PI3K/AKT/mTOR pathway inhibition in combination with all‐trans retinoic acid treatment for therapeutic gain in acute myeloid leukaemia. British Journal of Haematology. 198(2). 338–348. 17 indexed citations

Lewicka, Aneta, et al.. (2022). Looking into the Eyes—In Vitro Models for Ocular Research. International Journal of Molecular Sciences. 23(16). 9158–9158. 17 indexed citations

Santos, Helena G. Dos, Deukwoo Kwon, Terrence Bradley, et al.. (2021). Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies. Clinical Cancer Research. 27(7). 1893–1903. 32 indexed citations

Szymański, Łukasz, Małgorzata Palusińska, Tino Schenk, et al.. (2020). Retinoic Acid and Its Derivatives in Skin. Cells. 9(12). 2660–2660. 132 indexed citations

Gil, Veronica, Govind Bhagat, Lydia Pleotis Howell, et al.. (2016). Deregulated expression of HDAC9 in B-cells promotes development of lymphoproliferative disease and lymphoma. Disease Models & Mechanisms. 9(12). 1483–1495. 39 indexed citations

Doulatov, Sergei, Faiyaz Notta, Kim L. Rice, et al.. (2009). PLZF is a regulator of homeostatic and cytokine-induced myeloid development. Genes & Development. 23(17). 2076–2087. 79 indexed citations

Maeda, Takahiro, Taha Merghoub, Robin M. Hobbs, et al.. (2007). Regulation of B Versus T Lymphoid Lineage Fate Decision by the Proto-Oncogene LRF. Science. 316(5826). 860–866. 174 indexed citations

10.

Guidez, Fabien, Louise Howell, Mark Isalan, et al.. (2005). Histone Acetyltransferase Activity of p300 Is Required for Transcriptional Repression by the Promyelocytic Leukemia Zinc Finger Protein. Molecular and Cellular Biology. 25(13). 5552–5566. 90 indexed citations

11.

Buluwela, Laki, Joanna Pike, Danish Mazhar, et al.. (2005). Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZF. Gene Therapy. 12(5). 452–460. 13 indexed citations

12.

Sun, Yi, D-C Zhou, Wei Ding, et al.. (2004). Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide. Leukemia. 18(7). 1258–1269. 14 indexed citations

13.

Xu, Ke, Daniel C. Chung, Annegret Glasow, et al.. (2003). Dithiophenes potentiate differentiation of APL cells by lowering the threshold for ligand mediated co-repressor/co-activator exchange with RAR alpha and enhancing changes in ATRA regulated gene expression.. Blood. 102(11). 1 indexed citations

14.

Sirulnik, Andres, Ari Melnick, Arthur Zelent, & Jonathan D. Licht. (2003). Molecular pathogenesis of acute promyelocytic leukaemia and APL variants. Best Practice & Research Clinical Haematology. 16(3). 387–408. 37 indexed citations

15.

Guidez, Fabien, Lucia Altucci, Ke Xu, et al.. (2001). Rexinoid therapy bypasses the differentiation block associated with acute promyelocytic leukemia harboring the PLZF/RAR alpha rearrangement.. Blood. 98(11). 3 indexed citations

16.

Shaknovich, Rita, Patricia L. Yeyati, Sarah Ivins, et al.. (1998). The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and Apoptosis. Molecular and Cellular Biology. 18(9). 5533–5545. 149 indexed citations

17.

Geng, Jie, Tong Jian, Shuo Dong, et al.. (1993). Localization of the chromosome 15 breakpoints and expression of multiple PML-RAR alpha transcripts in acute promyelocytic leukemia: a study of 28 Chinese patients.. PubMed. 7(1). 20–6. 27 indexed citations

18.

Mattéi, Marie‐Geneviève, M. Rivière, Andrée Krust, et al.. (1991). Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes. Genomics. 10(4). 1061–1069. 63 indexed citations

19.

Price, Peter M., et al.. (1988). Translational Selection in the Expression of the Hepatitis B Virus Envelope Proteins. DNA. 7(6). 417–422. 7 indexed citations

20.

Banerjee, Ranjit, et al.. (1988). Identification of Protein-Binding Sites in the Hepatitis B Virus Enhancer and Core Promoter Domains. Molecular and Cellular Biology. 8(12). 5159–5165. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact